000 01393 a2200397 4500
005 20250517053149.0
264 0 _c20170526
008 201705s 0 0 eng d
022 _a1873-7064
024 7 _a10.1016/j.neuropharm.2015.09.019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeamer, Edward
245 0 0 _aPurinergic mechanisms in neuroinflammation: An update from molecules to behavior.
_h[electronic resource]
260 _bNeuropharmacology
_c05 2016
300 _a94-104 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xmetabolism
650 0 4 _aAdenosine Triphosphate
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aEncephalitis
_xcongenital
650 0 4 _aHumans
650 0 4 _aInflammasomes
_xmetabolism
650 0 4 _aInflammation Mediators
650 0 4 _aReceptor Cross-Talk
650 0 4 _aReceptors, Purinergic P1
_xmetabolism
650 0 4 _aReceptors, Purinergic P2
_xmetabolism
650 0 4 _aSignal Transduction
700 1 _aGölöncsér, Flóra
700 1 _aHorváth, Gergely
700 1 _aBekő, Katinka
700 1 _aOtrokocsi, Lilla
700 1 _aKoványi, Bence
700 1 _aSperlágh, Beáta
773 0 _tNeuropharmacology
_gvol. 104
_gp. 94-104
856 4 0 _uhttps://doi.org/10.1016/j.neuropharm.2015.09.019
_zAvailable from publisher's website
999 _c25275150
_d25275150